Specialty Chemicals
Search documents
Balchem Corporation Announces Quarterly Conference Call for Second Quarter 2025 Financial Results on July 31, 2025
GlobeNewswire News Room· 2025-07-17 11:00
Core Viewpoint - Balchem Corporation will hold a conference call on July 31, 2025, to discuss its second quarter 2025 results, with key executives participating [1][2]. Group 1: Conference Call Details - The second quarter results will be published before the market opens on July 31, 2025, and will be available on the company website [2]. - Participants can join the live call by dialing specific numbers or listening to the live webcast [3]. - The conference call will be available for replay for one year after the event [3]. Group 2: Company Overview - Balchem Corporation develops and markets specialty ingredients aimed at enhancing health and well-being across various industries [4]. - The company operates in three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products [4]. - The Human Nutrition & Health segment focuses on customized food and beverage ingredients, while the Animal Nutrition & Health segment supplies products for animal health markets [4].
Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter
Globenewswire· 2025-07-16 05:00
Financial Performance - Operating revenues increased to NOK 2,045 million in Q2 2025, up from NOK 1,949 million in the same period last year [1] - EBITDA reached NOK 522 million, compared to NOK 510 million in the previous year [1] - Profit before tax was NOK 326 million, slightly up from NOK 322 million [2] - Earnings per share increased to NOK 2.56 from NOK 2.45 [2] Segment Performance - BioSolutions saw improved results driven by continued growth in sales to agriculture [2][3] - BioMaterials experienced an increase in results due to higher sales prices, improved product mix, and increased sales volume, although this was partly offset by higher wood costs [2] - Fine Chemicals reported a weaker result primarily due to lower sales prices for bioethanol [2] Market Conditions - Positive net currency effects were noted across all areas [2] - The company’s President and CEO highlighted strong sales to agriculture and price increases for specialty cellulose as key drivers for improved results in BioSolutions and BioMaterials [3]
Stepan to Announce Second Quarter 2025 Results on July 30, 2025
Prnewswire· 2025-07-15 20:01
Core Viewpoint - Stepan Company will release its second quarter 2025 earnings results on July 30, 2025, followed by a conference call to discuss financial and operational performance [1][2]. Company Profile - Stepan Company is a major manufacturer of specialty and intermediate chemicals, particularly known for surfactants used in cleaning and disinfection products, as well as polyurethane polyols for thermal insulation [4]. - The company operates modern production facilities across North and South America, Europe, and Asia, and its stock is traded on the NYSE under the symbol SCL [5].
Corian® Design Launches "WOW That's Corian®!" to Showcase the Evolution and Future Possibilities of Solid Surface Design
Prnewswire· 2025-07-15 14:01
Core Insights - The launch of the "WOW That's Corian®!" global marketing campaign by Corian® Design highlights the innovative and versatile applications of Corian® Solid Surface beyond traditional uses, showcasing its evolution in modern design [1][2][4] - The campaign aims to connect with architects and designers by emphasizing the material's creative potential and performance across various industries, including healthcare, education, hospitality, and food service [2][4][5] Company Overview - Corian® Design, a division of DuPont Water & Protection, specializes in advanced materials for interior design and architecture, with a focus on beauty, functionality, and durability [8] - The Corian® brand is recognized for its pioneering role in solid surface materials, continuously evolving its product offerings to meet market demands [8][9] Product Features - Corian® Solid Surface is characterized by exceptional design versatility, available in a wide range of colors and capable of being thermoformed, backlit, and engraved, contributing to sustainable design by reducing replacement needs [3][4] - The material's non-porous, hygienic surface makes it ideal for high-touch areas in healthcare, while its adaptability supports dynamic learning environments in educational settings [4][6] Market Applications - In healthcare, Corian® Solid Surface is used for patient rooms and nurse stations due to its easy-to-clean properties and aesthetic appeal [4] - In educational environments, it fosters collaboration and creativity through sculptural designs and hygienic dining areas [4] - The hospitality industry benefits from Corian® Solid Surface in creating memorable guest experiences with unique design elements [4][5] Design Trends - The evolution of Corian® Solid Surface aligns with current design trends, including biophilic design and warm minimalism, with collections like Nature's Canvas reflecting nature-inspired aesthetics [6][7] - The material provides architects and designers with aesthetic freedom and functionality, enabling the creation of contemporary yet timeless spaces [7]
Magnera to Report 2025 Third Quarter Results on August 6th
Globenewswire· 2025-07-15 14:00
Company Overview - Magnera Corporation (NYSE: MAGN) serves over 1,000 customers globally, providing a diverse range of material solutions including components for absorbent hygiene products, protective apparel, wipes, specialty building and construction products, and products for the food and beverage industry [3] - The company operates across 46 production facilities and is supported by more than 9,000 employees worldwide [3] Upcoming Financial Results - Magnera is set to release its 2025 third quarter results before trading on the New York Stock Exchange on August 6, 2025 [1] - A conference call to discuss the financial results will take place at 10:00 a.m. ET on the same day, with options for Q&A and a webcast available [2] Company Mission and History - Magnera's mission is to improve the world by providing new possibilities through material solutions, having delivered these solutions for over 160 years [4] - The company has consistently adapted to economic challenges, global pandemics, and changing customer needs, maintaining strong partnerships and a comprehensive product portfolio [4]
Operations leadership changes announced at Ashland
Globenewswire· 2025-07-14 21:00
Core Insights - Ashland Inc. announced the retirement of Karl Bostaph, senior vice president of operations, effective October 1, 2025 [1] - Wayne Muil, global director of operations for specialty additives, will succeed Bostaph in the role of senior vice president of operations [3][4] Leadership Transition - Bostaph has been with the company since 1990, holding various roles in Research and Development, Quality, Engineering, and Manufacturing [2] - Muil joined Ashland in 2024 and has over 25 years of experience in the chemical industry, including leadership roles at Sadara Chemical Company [5][6] - Muil is recognized for his strategic vision and expertise in operational excellence, safety, and innovation across global production facilities [7] Company Overview - Ashland Inc. is a global additives and specialty ingredients company focused on environmental, social, and governance (ESG) initiatives [8] - The company serves diverse markets, including architectural coatings, construction, energy, food and beverage, personal care, and pharmaceuticals, with a workforce of approximately 2,960 employees [8]
Solvay revises its 2025 underlying EBITDA outlook and confirms its Free cash flow guidance
Globenewswire· 2025-07-14 17:18
Group 1 - Solvay is facing a challenging market environment in Q2 2025, influenced by global tariff discussions and geopolitical tensions, leading to reduced demand and slower order books, particularly in soda ash end-markets and the Coatis business unit [1] - The company has updated its 2025 outlook, now expecting underlying EBITDA to be between €880 million and €930 million, down from a previous range of €1.0 billion to €1.1 billion [2] - Solvay anticipates Free Cash Flow from continued operations to be around €300 million, with a maximum of €300 million in capital expenditures, reflecting a focus on cash generation and dividend coverage [3] Group 2 - In Q2 2025, Solvay expects an underlying EBITDA of approximately €230 million, which includes a one-off revenue gain of around €20 million from the Special Chem business unit [3] - The company will not provide further comments ahead of the Q2 2025 earnings release scheduled for July 30 [4] - Solvay, a leading chemical company with a history dating back to 1863, reported underlying net sales of €4.7 billion in 2024 and is committed to sustainability and a carbon-neutral future by 2050 [4]
Stepan Announces Appointment of New Vice President and Chief Financial Officer
Prnewswire· 2025-07-14 11:00
Group 1 - Stepan Company announced the appointment of Ruben Velasquez as Vice President and Chief Financial Officer, effective July 15, 2025, succeeding Samuel Hinrichsen [1] - Mr. Velasquez has over two decades of global finance leadership experience across various industries, including industrial conglomerates and oil and gas [3] - The company is a major manufacturer of specialty and intermediate chemicals, leading in surfactants and polyurethane polyols for various markets [3][4] Group 2 - Stepan Company is headquartered in Northbrook, Illinois, and operates modern production facilities across North and South America, Europe, and Asia [4] - The company's common stock is traded on the New York Stock Exchange under the symbol SCL [4]
Cabot Corporation Board Declares Dividend
Globenewswire· 2025-07-11 21:00
Group 1 - Cabot Corporation declared a quarterly dividend of $0.45 per share on all outstanding shares of its common stock, payable on September 11, 2025, to stockholders of record at the close of business on August 29, 2025 [1] - Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts, providing a range of products including reinforcing carbons, specialty carbons, battery materials, and more [2] Group 2 - The company is listed on the New York Stock Exchange under the ticker symbol CBT [2]
Northern Technologies International Corporation Reports Financial Results for Third Quarter Fiscal 2025
Globenewswire· 2025-07-10 12:00
Core Insights - Northern Technologies International Corporation (NTIC) reported a 4.0% increase in consolidated net sales for Q3 fiscal 2025, reaching $21.51 million compared to $20.69 million in Q3 fiscal 2024, driven by demand for ZERUST® industrial products despite geopolitical tensions [4][6][20] - The company continues to invest in its ZERUST® oil and gas business, expecting sequential growth in sales and profitability in Q4 fiscal 2025 and into fiscal 2026, with cumulative sales of $24 million over the past 13 quarters [2][3] - NTIC is monitoring European economic stimulus packages, particularly in Germany, which may positively impact joint venture operating income [3] Financial Performance - Consolidated net sales for the nine months ended May 31, 2025, increased by 0.3% to $61.92 million from $61.71 million in the same period last year [4][20] - ZERUST® industrial net sales rose by 7.1% to $14.44 million, while ZERUST® oil and gas net sales decreased by 5.3% to $1.29 million [5][6] - Gross profit margin increased by 20 basis points to 38.4%, while operating expenses rose by 7.6% to $9.67 million [6][7] Income and Earnings - Net income attributable to NTIC for Q3 fiscal 2025 was $122,000, or $0.01 per diluted share, down from $977,000, or $0.10 per diluted share, in Q3 fiscal 2024 [9][21] - Year-to-date net income attributable to NTIC was $1.12 million, or $0.12 per diluted share, compared to $3.57 million, or $0.36 per diluted share, for the same period last year [9][21] - Non-GAAP adjusted net income for Q3 fiscal 2025 was $228,000, or $0.02 per diluted share, compared to $1.08 million, or $0.11 per diluted share, for the same quarter last fiscal year [10][25] Joint Ventures and Investments - NTIC's joint venture operating income decreased by 12.9% to $2.27 million in Q3 fiscal 2025, primarily due to lower sales and reduced equity income from joint ventures [7][20] - The company had $27.14 million in investments in joint ventures as of May 31, 2025, with $13.50 million in cash [12][18] Balance Sheet Highlights - As of May 31, 2025, NTIC had working capital of $21.66 million, including $6.77 million in cash and cash equivalents [11][18] - Total assets increased to $99.30 million from $94.68 million as of August 31, 2024 [18][19]